Meet the Skin Expert at Paris Spa FREE! Facial Skin Analysis During June 24-29, 2013

Food and Healthcare Press Releases Thursday June 20, 2013 12:15
Bangkok--20 Jun--Maxima Consultants

Paris Spa invites skin lovers to get the Free! Facial Skin analysis by the revolutionary technology, Electronic Eye machine and meet the professional skin specialist Ms.Vita Viluckaite from Valmont, Switzerland. The Free facial skin analysis will be offered at Paris Spa branches during June 24-29, 2013 at 10:00 hrs - 18:00 hrs.

The skin specialist will educate your skin condition and the proper treatment will be recommended to suit skin. For reservations to meet the skin specialist, please contact Paris Spa Chidlom at Tel 02-655-2550, 02-254-8354 or Paris Spa at Peninsula Branch at Tel 02-652-2186.

Discover the secrets of ageless skin with Valmont!

Latest Press Release

ESMO Emphasises Importance of Cancer on Global Health Agenda at WHA

At the World Health Assembly in Geneva, ESMO delivered two statements positioning cancer as a priority on the WHO global agenda. (Photo: https://mma.prnewswire.com/media/696385/WHA_Global_Health_Agenda.jpg ) ESMO advocated the strengthening of health...

Real-World Evidence Shows Clinically Meaningful Weight Loss in People Receiving Saxenda(R)

People treated with Saxenda(R) (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in a real-world clinical setting, in combination with diet and exercise. The data were presented this week at both the 25th European...

Venus Medtech#s strategic investment in Keystone Heart deepens the technical layout of cerebral embolic protection market

China Venus Medtech (Hangzhou) Inc. announced a partnership agreement for strategic investment and authorization with Keystone Heart. This agreement will grant Venus Medtech the right to exclusively develop, manufacture and sell the 3rd generation...

WCG (WIRB-Copernicus Group) Clinical Services Division Opens Office in Japan

WCG(TM) (WIRB-Copernicus Group(R)) Clinical Services Division, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced the opening of the company's new office in Tokyo, Japan....

Head-to-Head Trial Shows Refixia(R) Achieves Greater Total Factor IX Exposure in People With Haemophilia B Than Recombinant Factor IX-Fc Fusion Protein

Adults with haemophilia B who received a single dose Refixia(R) (nonacog beta pegol; N9-GP) achieved greater total factor IX exposure than those treated with rFIXFc (recombinant factor IX-Fc fusion protein). The head-to-head paradigm7 trial also observed...

Related Topics